Case Series: Cancer-Related Facial Pain Treated with Stellate Ganglion Block
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2020-12-02
Language
American English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Mary Ann Liebert, Inc.
Abstract
Stellate ganglion block (SGB) is believed to modify the pathologic sympathetic pain response and has been commonly used to treat complex regional pain syndrome. We report successful treatment of cancer-related facial pain with SGB in three patients, suggesting a possible sympathetic pain-related mechanism. All patients exhibited clinically significant improvement of pain 12 weeks following the procedure. SGB should be considered a palliative pain treatment option in cancer-related facial pain.
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Darabad RR, Kalangara JP, Woodbury A. Case Series: Cancer-Related Facial Pain Treated with Stellate Ganglion Block. Palliat Med Rep. 2020;1(1):290-295. Published 2020 Dec 2. doi:10.1089/pmr.2020.0042
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Palliative Medicine Reports
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Final published version